Food, Drugs, Healthcare, Life Sciences

The Supreme Court of Appeals of West Virginia declined to decide whether West Virginia allows for public nuisance claims against distributors of prescription opioids.

On June 11, 2025, was published in the DOF the "AGREEMENT recognizing as equivalent the requirements established in the Health Regulation and the technical evaluation procedures...

On June 12, 2025, BioNTech SE ("BioNTech") announced its entry into a definitive purchase agreement to acquire all shares of CureVac N.V. ("CureVac"), with an implied aggregate equity value for CureVac of approximately $1.25 billion.

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.

The Supreme Court of Appeals of West Virginia declined to decide whether West Virginia allows for public nuisance claims against distributors of prescription opioids.

The House passed the first FY26 appropriations bill (MilCon-VA) this week by a vote of 218–206.

In part two of this three-part series on the Attorney General Alliance (AGA) 2025 Annual Meeting, we highlight panelists' discussions on the safety and regulation of GLP-1...

Since the Dobbs v. Jackson Women's Health Organization decision (which overturned the landmark Roe v. Wade decision), the healthcare industry has continued to grapple with renewed concerns over patient privacy and reproductive healthcare.

Explained in more detail below, under the recent vacatur of most of the HIPAA Privacy Rule to Support Reproductive Health Care Privacy (the "Reproductive Health Rule")...

The Trump Administration has reaffirmed its commitment to aggressive health care enforcement, continuing the priorities of the previous administration.